Persistent knee pain in a patient with systemic lupus erythematosus

The evaluation of chronic kidney disease-mineral and bone disorder (CKD-MBD) is based on clinical, laboratory, radiology and histological data. However, these data may not always be entirely concordant, leading to significant doubt over therapeutic options. We present a challenging CKD-MBD case report. A 26-year-old female patient presented a past medical history of systemic erythematosus lupus and end-stage renal disease. She had been on hemodialysis and transited to peritoneal dialysis due to multiple vascular access failure. Medication included calcium carbonate, cholecalciferol, calcitriol, and cinacalcet but adherence to medication was low, leading to PTH values often higher than 1000 pg/mL. She presented right knee pain for two months. Radiology exams revealed iliac, femoral and tibial osteolytic lesions. A bone biopsy was performed, detecting disperse multinucleated giant cells compatible with brown tumors. However, poor therapeutic adherence did not allow persistent control of hyperparathyroidism, with PTH levels often >1000 pg/mL, and parathyroidectomy was considered. A tetracycline-labeled bone biopsy showed high turnover bone disease in the past, evolving to low-bone turnover/adynamic bone disease. This led to the decision of optimizing medical treatment and avoiding parathyroidectomy. Significant clinical improvement was observed with knee pain resolution and transient reduction of PTH to stage 5 chronic kidney disease reference levels. Four years later an imagiological re-evaluation was performed, revealing bilateral tibial, femoral and iliac enlarged bone lesions, and bone scintigraphy confirmed hypermetabolic lesions. She was then submitted to subtotal parathyroidectomy and subsequently to deceased-donor renal transplantation. This case report shows the importance of closely following CKD-MBD patients, even in asymptomatic patients. Treatment decision should not solely include bone histology criteria. Repeated evaluations at different time points of clinical, laboratory, and radiology data might be particularly useful

Saved in:
Bibliographic Details
Main Authors: Vieira,Miguel Bigotte, Dias,Joana Monteiro, Romeu,José Carlos, Pereira,Marta, Abreu,Cristina Pinto de
Format: Digital revista
Language:English
Published: Sociedade Portuguesa de Nefrologia 2018
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692018000400008
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0872-01692018000400008
record_format ojs
spelling oai:scielo:S0872-016920180004000082019-02-18Persistent knee pain in a patient with systemic lupus erythematosusVieira,Miguel BigotteDias,Joana MonteiroRomeu,José CarlosPereira,MartaAbreu,Cristina Pinto de Chronic kidney disease-mineral and bone disorder hyperparathyroidism brown tumor The evaluation of chronic kidney disease-mineral and bone disorder (CKD-MBD) is based on clinical, laboratory, radiology and histological data. However, these data may not always be entirely concordant, leading to significant doubt over therapeutic options. We present a challenging CKD-MBD case report. A 26-year-old female patient presented a past medical history of systemic erythematosus lupus and end-stage renal disease. She had been on hemodialysis and transited to peritoneal dialysis due to multiple vascular access failure. Medication included calcium carbonate, cholecalciferol, calcitriol, and cinacalcet but adherence to medication was low, leading to PTH values often higher than 1000 pg/mL. She presented right knee pain for two months. Radiology exams revealed iliac, femoral and tibial osteolytic lesions. A bone biopsy was performed, detecting disperse multinucleated giant cells compatible with brown tumors. However, poor therapeutic adherence did not allow persistent control of hyperparathyroidism, with PTH levels often >1000 pg/mL, and parathyroidectomy was considered. A tetracycline-labeled bone biopsy showed high turnover bone disease in the past, evolving to low-bone turnover/adynamic bone disease. This led to the decision of optimizing medical treatment and avoiding parathyroidectomy. Significant clinical improvement was observed with knee pain resolution and transient reduction of PTH to stage 5 chronic kidney disease reference levels. Four years later an imagiological re-evaluation was performed, revealing bilateral tibial, femoral and iliac enlarged bone lesions, and bone scintigraphy confirmed hypermetabolic lesions. She was then submitted to subtotal parathyroidectomy and subsequently to deceased-donor renal transplantation. This case report shows the importance of closely following CKD-MBD patients, even in asymptomatic patients. Treatment decision should not solely include bone histology criteria. Repeated evaluations at different time points of clinical, laboratory, and radiology data might be particularly usefulinfo:eu-repo/semantics/openAccessSociedade Portuguesa de NefrologiaPortuguese Journal of Nephrology & Hypertension v.32 n.4 20182018-12-01info:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692018000400008en
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Vieira,Miguel Bigotte
Dias,Joana Monteiro
Romeu,José Carlos
Pereira,Marta
Abreu,Cristina Pinto de
spellingShingle Vieira,Miguel Bigotte
Dias,Joana Monteiro
Romeu,José Carlos
Pereira,Marta
Abreu,Cristina Pinto de
Persistent knee pain in a patient with systemic lupus erythematosus
author_facet Vieira,Miguel Bigotte
Dias,Joana Monteiro
Romeu,José Carlos
Pereira,Marta
Abreu,Cristina Pinto de
author_sort Vieira,Miguel Bigotte
title Persistent knee pain in a patient with systemic lupus erythematosus
title_short Persistent knee pain in a patient with systemic lupus erythematosus
title_full Persistent knee pain in a patient with systemic lupus erythematosus
title_fullStr Persistent knee pain in a patient with systemic lupus erythematosus
title_full_unstemmed Persistent knee pain in a patient with systemic lupus erythematosus
title_sort persistent knee pain in a patient with systemic lupus erythematosus
description The evaluation of chronic kidney disease-mineral and bone disorder (CKD-MBD) is based on clinical, laboratory, radiology and histological data. However, these data may not always be entirely concordant, leading to significant doubt over therapeutic options. We present a challenging CKD-MBD case report. A 26-year-old female patient presented a past medical history of systemic erythematosus lupus and end-stage renal disease. She had been on hemodialysis and transited to peritoneal dialysis due to multiple vascular access failure. Medication included calcium carbonate, cholecalciferol, calcitriol, and cinacalcet but adherence to medication was low, leading to PTH values often higher than 1000 pg/mL. She presented right knee pain for two months. Radiology exams revealed iliac, femoral and tibial osteolytic lesions. A bone biopsy was performed, detecting disperse multinucleated giant cells compatible with brown tumors. However, poor therapeutic adherence did not allow persistent control of hyperparathyroidism, with PTH levels often >1000 pg/mL, and parathyroidectomy was considered. A tetracycline-labeled bone biopsy showed high turnover bone disease in the past, evolving to low-bone turnover/adynamic bone disease. This led to the decision of optimizing medical treatment and avoiding parathyroidectomy. Significant clinical improvement was observed with knee pain resolution and transient reduction of PTH to stage 5 chronic kidney disease reference levels. Four years later an imagiological re-evaluation was performed, revealing bilateral tibial, femoral and iliac enlarged bone lesions, and bone scintigraphy confirmed hypermetabolic lesions. She was then submitted to subtotal parathyroidectomy and subsequently to deceased-donor renal transplantation. This case report shows the importance of closely following CKD-MBD patients, even in asymptomatic patients. Treatment decision should not solely include bone histology criteria. Repeated evaluations at different time points of clinical, laboratory, and radiology data might be particularly useful
publisher Sociedade Portuguesa de Nefrologia
publishDate 2018
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692018000400008
work_keys_str_mv AT vieiramiguelbigotte persistentkneepaininapatientwithsystemiclupuserythematosus
AT diasjoanamonteiro persistentkneepaininapatientwithsystemiclupuserythematosus
AT romeujosecarlos persistentkneepaininapatientwithsystemiclupuserythematosus
AT pereiramarta persistentkneepaininapatientwithsystemiclupuserythematosus
AT abreucristinapintode persistentkneepaininapatientwithsystemiclupuserythematosus
_version_ 1756001694015029248